Group One Trading’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03K | Sell |
649
-2,693
| -81% | -$4.28K | ﹤0.01% | 1843 |
|
|
2025
Q1 | $4.98K | Sell |
3,342
-1,475
| -31% | -$2.2K | ﹤0.01% | 1566 |
|
|
2024
Q4 | $19.3K | Buy |
4,817
+3,991
| +483% | +$16K | ﹤0.01% | 1417 |
|
|
2024
Q3 | $10.3K | Sell |
826
-128
| -13% | -$1.6K | ﹤0.01% | 1271 |
|
|
2024
Q2 | $13.9K | Buy |
954
+171
| +22% | +$2.5K | ﹤0.01% | 1246 |
|
|
2024
Q1 | $17.6K | Sell |
783
-241
| -24% | -$5.4K | ﹤0.01% | 1179 |
|
|
2023
Q4 | $19.4K | Hold |
1,024
| – | – | ﹤0.01% | 1272 |
|
|
2023
Q3 | $17.5K | Buy |
+1,024
| New | +$17.5K | ﹤0.01% | 1307 |
|
|
2023
Q2 | – | Sell |
-1,956
| Closed | -$57.2K | – | 2139 |
|
|
2023
Q1 | $57.2K | Sell |
1,956
-423
| -18% | -$12.4K | ﹤0.01% | 981 |
|
|
2022
Q4 | $47K | Buy |
2,379
+652
| +38% | +$12.9K | ﹤0.01% | 1104 |
|
|
2022
Q3 | $52K | Buy |
+1,727
| New | +$52K | ﹤0.01% | 1218 |
|